ArticleUpdates in surgery2026
Evolution of robotic-assisted resection of pediatric neuroblastic tumors: a retrospective analysis.
Article in Updates in surgery, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Due to rarity and variability in pediatric tumors presentation, robotic oncologic surgery remains a challenging field. This study analyses clinical features that can impact outcomes of robotic excision of neuroblastic tumors (pNBTs) in children. Retrospective cohort of children who underwent robotic resection of pNBTs between 2020 and 2025. Exclusion criteria: biopsy only, follow-up ≤ 6 months. Forty-four children included, 24 girls (54.5%), 68.1% neuroblastoma, 18.1% ganglioneuroblastoma intermixed, 13.6% ganglioneuroma. Abdominal tumors were described in 33 (75%). At surgery 61.3% had a IDRFpositive status. Median age was 36 months (IQR 17-63) with a median weight of 12 kg (IQR 9.6-22). Median operative time was 170 min (IQR 130-210). Ten (22.7%) conversions occurred, with a single urgent de-docking. No incomplete resection was recorded. Median hospitalization was 3 days (IQR 2-5). Two (4.5%) early post-operative complications: two incisional eventration (IIIb Clavien-Dindo). There was no statistical difference in conversion and complications rates between patients ≤ 10 kg (31.8%) and children > 10 kg. Risk factor analysis showed higher conversion rate in children with higher IDRF score (p = 0.032). Uneventful oncological follow-up. Robotic surgery seems a safe option for pNBTs resection in carefully selected children. This study suggests IDRF score might be helpful in selecting patients for robotic approach, to limit the chances of minimal residual tumor and/or conversion. The robotic approach should be performed by surgeons with extensive experience in robotic surgery and a strong expertise of oncological principles.
Indexed as
Identifiers
42635707What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.